Nektar Therapeutics (NKTR) Dropped from S&P SmallCap 600

Crane Co. (NYSE: CR) will be added to the S&P MidCap 400 effective prior to the open of trading on Tuesday, April 4, replacing PacWest Bancorp (NASD: PACW) which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 5. PacWest Bancorp will replace Nektar Therapeutics (NASD: NKTR) in the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 5. S&P MidCap 400 constituent Crane Holdings Co. (NYSE: CR) is spinning off new Crane in a transaction expected to be completed on April 4. Following the spin-off, the parent Crane Holdings Co. will have a name change to Crane NXT Co., a symbol change to CXT, and will remain in the S&P MidCap 400. Nektar Therapeutics is no longer representative of the small cap market space.

You May Also Be Interested In

• Nektar Therapeutics (NKTR) Tops Q2 EPS by 77c
• U.S. Physical Therapy names Nchacha Etta as CFO, effective Sept. 2026
• Faeth Therapeutics names two SVPs ahead of clinical milestones